Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-Emptive Initiation of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema Improves Outcomes: A Randomized Controlled Trial.

Alimentary pharmacology & therapeutics·2026
Same author

Effect of testosterone addition to nutrition and exercise on muscle mass in men with cirrhosis: the next trial.

Hepatology international·2026
Same author

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same author

Steatotic liver disease in Latin America: current views and perspectives.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Rethinking endpoints in alcohol-associated hepatitis: A composite approach for real-world care.

Hepatology (Baltimore, Md.)·2026
Same journal

Financial burden among liver transplant candidates is associated with financial distress and work impairment: A U.S. multicenter study.

Hepatology communications·2026
Same journal

Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm.

Hepatology communications·2026
Same journal

Hepatology e-consult responses generated by artificial intelligence demonstrate accuracy but require human oversight.

Hepatology communications·2026
Same journal

The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.

Hepatology communications·2026
Same journal

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026
Same journal

The PERK-GADD45A axis is a key driver of hepatic stellate cell activation.

Hepatology communications·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.2K

Moderate alcohol-associated hepatitis: A real-world multicenter study.

Francisco Idalsoaga1,2, Luis Antonio Díaz1,3, Winston Dunn4

  • 1Departamento De Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile.

Hepatology Communications
|March 25, 2025
PubMed
Summary
This summary is machine-generated.

Moderate alcohol-associated hepatitis (mAH) patients have a 6-month mortality of 11.8%, mainly from organ failure and infections. Current scoring systems poorly predict outcomes for mAH, necessitating new models.

More Related Videos

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
05:40

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

Published on: April 28, 2022

2.9K
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

815

Related Experiment Videos

Last Updated: May 31, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.2K
The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
05:40

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

Published on: April 28, 2022

2.9K
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

815

Area of Science:

  • Hepatology
  • Internal Medicine
  • Gastroenterology

Background:

  • Severe alcohol-associated hepatitis (sAH) is well-studied, but moderate alcohol-associated hepatitis (mAH) is under-researched.
  • Limited data exists on the characteristics and outcomes of patients with mAH.

Purpose of the Study:

  • To characterize patients with moderate alcohol-associated hepatitis (mAH).
  • To evaluate the performance of existing mortality scoring systems in mAH.
  • To identify key prognostic factors and survival trends in mAH.

Main Methods:

  • Multicenter retrospective cohort study (2009-2019).
  • Included patients with mAH (MELD score ≤20 at admission).
  • Utilized Cox regression and receiver operating characteristic (ROC) curves with AUC analysis.

Main Results:

  • 24% of 1845 AH patients met mAH criteria (MELD ≤20).
  • mAH patients were older, more frequently female, with median MELD 17, mDF 33, bilirubin trajectory 0.83, and NLR 5.
  • 6-month mortality was 11.8%, primarily due to multiple organ failure (34.1%) and infections (16.6%). Age was the sole significant predictor of 30-day mortality (HR 1.49).
  • Mortality prediction models showed poor performance (MELD AUC 0.671, mDF AUC 0.726, bilirubin AUC 0.733, NLR AUC 0.697).

Conclusions:

  • Moderate AH patients have a distinct clinical profile and significant 6-month mortality (11.8%) driven by organ failure and infections.
  • Existing scoring systems (MELD, mDF, bilirubin, NLR) demonstrate limited predictive accuracy for mAH outcomes.
  • Tailored predictive models and therapeutic strategies are essential to enhance long-term outcomes in moderate alcohol-associated hepatitis.